Search research articles
Contact Us
Filters
Showing results (251-260 of 257) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 257 results.
Journal of Clinical and Translational Science
|
February 27, 2023
Barriers to and solutions for representative inclusion across the lifespan and in life course research: The need for structural competency highlighted by the COVID-19 pandemic
Madison N LeCroy, Lindsey N Potter, Karen Bandeen-Roche, et al.
Plos One
|
March 24, 2016
Correction: Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus
Chantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, et al.
Blood Advances
|
July 29, 2021
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma
Jonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 3, 2019
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study
Neema P Mayor, James D Hayhurst, Thomas R Turner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 14, 2019
A reply to Hurley et al. regarding Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study
Neema P Mayor, James D Hayhurst, Thomas R Turner, et al.
Bone Marrow Transplantation
|
March 24, 2020
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML
Will P Bultitude, Jennifer Schellekens, Richard M Szydlo, et al.
Blood Advances
|
July 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
Malgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 257) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 257 results.
Journal of Clinical and Translational Science
|
February 27, 2023
Barriers to and solutions for representative inclusion across the lifespan and in life course research: The need for structural competency highlighted by the COVID-19 pandemic
Madison N LeCroy, Lindsey N Potter, Karen Bandeen-Roche, et al.
Plos One
|
March 24, 2016
Correction: Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus
Chantal E Hargreaves, Chisako Iriyama, Matthew J J Rose-Zerilli, et al.
Blood Advances
|
July 29, 2021
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma
Jonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 3, 2019
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study
Neema P Mayor, James D Hayhurst, Thomas R Turner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 14, 2019
A reply to Hurley et al. regarding Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study
Neema P Mayor, James D Hayhurst, Thomas R Turner, et al.
Bone Marrow Transplantation
|
March 24, 2020
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML
Will P Bultitude, Jennifer Schellekens, Richard M Szydlo, et al.
Blood Advances
|
July 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
Malgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, et al.
Page
of 26